ConductScience.org, home

Paper23089736

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.

Sheehy SH and 31 others. Mol Ther, 2012. Cited by 176 papers, by iCite.

Cite this record

ConductScience Library. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Papers, record 23089736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23089736

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
PubMed
Journal
Mol Ther
PubMed
Year
2012
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
176
iCite
Relative citation ratio, by iCite
5.16
iCite
Revised in PubMed
2025-05-29
PubMed

Authors32

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheehy SHSusanne H
2Duncan CJChristopher J A
3Elias SCSean C
4Choudhary PPrateek
5Biswas SSumi
6Halstead FDFenella D
7Collins KAKatharine A
8Edwards NJNick J
9Douglas ADAlexander D
10Anagnostou NANicholas A
11Ewer KJKatie J
12Havelock TTom
13Mahungu TTabitha
14Bliss CMCarly M
15Miura KKazutoyo
16Poulton IDIan D
17Lillie PJPatrick J
18Antrobus RDRichard D
19Berrie EEleanor
20Moyle SSarah

Source PubMed

See all 32 authorsDownload CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ProtozoanMajor topic
CulicidaeMajor topic
Malaria VaccinesMajor topic
Merozoite Surface Protein 1Major topic
Adenoviruses, Simian
Animals
Flow Cytometry
Humans
Malaria, Falciparum
Orthopoxvirus
Pan troglodytes

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
G0700735(82115)Medical Research CouncilUnited KingdomPubMedPubMed
G1000527Medical Research CouncilUnited KingdomPubMedPubMed
094449/Z/10/ZWellcome TrustUnited KingdomPubMedPubMed
095540Wellcome TrustUnited KingdomPubMedPubMed
090532Wellcome TrustUnited KingdomPubMedPubMed
084113/Z/07/ZWellcome TrustUnited KingdomPubMedPubMed
45488/Z/05Wellcome TrustUnited KingdomPubMedPubMed
G1000527(95710)Medical Research CouncilUnited KingdomPubMedPubMed
G0700735Medical Research CouncilUnited KingdomPubMedPubMed
ZIAAI001020NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02485912Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost VaccinationBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in23201615Still seeking an effective "one-two" malaria vaccine punch.https://conductscience.org/library/papers/23201615

Source PubMed

Download CSV of comments and corrections

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119857448
Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.
Vaccine2009https://conductscience.org/library/papers/19857448PubMed
21625908Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.Parasite Immunol1992https://conductscience.org/library/papers/1625908PubMed
319627632The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria.Parasitology2009https://conductscience.org/library/papers/19627632PubMed
410861076CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.J Immunol2000https://conductscience.org/library/papers/10861076PubMed
510462251Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant.Vaccine1999https://conductscience.org/library/papers/10462251PubMed
62258697Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.J Exp Med1990https://conductscience.org/library/papers/2258697PubMed
721876036Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.J Immunol2011https://conductscience.org/library/papers/21876036PubMed
822186897The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.Nat Commun2011https://conductscience.org/library/papers/22186897PubMed
917015763Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes.J Immunol2006https://conductscience.org/library/papers/17015763PubMed
1022363582Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.PLoS One2012https://conductscience.org/library/papers/22363582PubMed
1122275401Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.J Infect Dis2012https://conductscience.org/library/papers/22275401PubMed
1215655787
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.
J Infect Dis2005https://conductscience.org/library/papers/15655787PubMed
1311738714Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR.Mol Biochem Parasitol2001https://conductscience.org/library/papers/11738714PubMed
1422492136Controlled human blood stage malaria infection: current status and potential applications.Am J Trop Med Hyg2012https://conductscience.org/library/papers/22492136PubMed
1518660818Effective induction of high-titer antibodies by viral vector vaccines.Nat Med2008https://conductscience.org/library/papers/18660818PubMed
1616014857Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.Am J Trop Med Hyg2005https://conductscience.org/library/papers/16014857PubMed
1722218690Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.Sci Transl Med2012https://conductscience.org/library/papers/22218690PubMed
1819154991Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.Cell Host Microbe2009https://conductscience.org/library/papers/19154991PubMed
1915306710Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.Am J Trop Med Hyg2004https://conductscience.org/library/papers/15306710PubMed
2012241933Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.Lancet2002https://conductscience.org/library/papers/12241933PubMed

See all 50 referencesDownload CSV of references

Cited by144

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 176 citations.

PMIDTitleJournalYearIn PapersSource
42504823An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies.Elife2026https://conductscience.org/library/papers/42504823PubMed
42497177Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid.PLoS Pathog2026https://conductscience.org/library/papers/42497177PubMed
42159668Adenoviral Vectors in Gene Therapy: A Detailed Overview.Iran Biomed J2026https://conductscience.org/library/papers/42159668PubMed
41970240
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults.
Wellcome Open Res2024https://conductscience.org/library/papers/41970240PubMed
41545594Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.Nat Med2026https://conductscience.org/library/papers/41545594PubMed
41405971Harnessing controlled human infection models to accelerate vaccine development for neglected tropical diseases: Lessons from leishmaniasis.Eur J Clin Invest2026https://conductscience.org/library/papers/41405971PubMed
41050675Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.Front Immunol2025https://conductscience.org/library/papers/41050675PubMed
40563989Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions.Biomedicines2025https://conductscience.org/library/papers/40563989PubMed
39893367Controlled human malaria infection: overview and potential application in the evaluation of transmission-blocking interventions in malaria-endemic areas.Malar J2025https://conductscience.org/library/papers/39893367PubMed
39628785Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution.Eng Microbiol2024https://conductscience.org/library/papers/39628785PubMed
38803222Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.Life Sci Alliance2024https://conductscience.org/library/papers/38803222PubMed
38506710Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.Clin Cancer Res2024https://conductscience.org/library/papers/38506710PubMed
38184681PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.NPJ Vaccines2024https://conductscience.org/library/papers/38184681PubMed
38098083A dual-antigen malaria vaccine targeting Pb22 and Pbg37 was able to induce robust transmission-blocking activity.Parasit Vectors2023https://conductscience.org/library/papers/38098083PubMed
37626150Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.Sci Rep2023https://conductscience.org/library/papers/37626150PubMed
37558673Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.NPJ Vaccines2023https://conductscience.org/library/papers/37558673PubMed
37515003Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA.Vaccines (Basel)2023https://conductscience.org/library/papers/37515003PubMed
37310872The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study.Elife2023https://conductscience.org/library/papers/37310872PubMed
36985500Natural Plasmodium falciparum Infection Stimulates Human Antibodies to MSP1 Epitopes Identified in Mice Infection Models upon Non-Natural Modified Peptidomimetic Vaccination.Molecules2023https://conductscience.org/library/papers/36985500PubMed
36365010Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs.Pathogens2022https://conductscience.org/library/papers/36365010PubMed

See all 144 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23089736

GET https://conductscience.org/api/papers/v1/23089736/authors?page=2